Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Acquired by Exchange Traded Concepts LLC

Exchange Traded Concepts LLC raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.5% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 42,891 shares of the medical equipment provider’s stock after purchasing an additional 2,225 shares during the quarter. Exchange Traded Concepts LLC’s holdings in Intuitive Surgical were worth $21,243,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of ISRG. Brighton Jones LLC grew its stake in Intuitive Surgical by 24.9% during the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after purchasing an additional 731 shares in the last quarter. Union Bancaire Privee UBP SA acquired a new stake in Intuitive Surgical during the 4th quarter valued at approximately $6,509,000. Bank of Stockton grew its stake in Intuitive Surgical by 13.5% during the 4th quarter. Bank of Stockton now owns 1,161 shares of the medical equipment provider’s stock valued at $606,000 after purchasing an additional 138 shares in the last quarter. Vontobel Holding Ltd. grew its stake in Intuitive Surgical by 5.8% during the 4th quarter. Vontobel Holding Ltd. now owns 48,776 shares of the medical equipment provider’s stock valued at $25,459,000 after purchasing an additional 2,655 shares in the last quarter. Finally, First Merchants Corp acquired a new stake in Intuitive Surgical during the 4th quarter valued at approximately $201,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In other news, Director Jami K. Nachtsheim sold 2,400 shares of the business’s stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $520.00, for a total value of $1,248,000.00. Following the transaction, the director now directly owns 6,371 shares of the company’s stock, valued at $3,312,920. The trade was a 27.36% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Mark Brosius sold 215 shares of the business’s stock in a transaction that occurred on Monday, June 2nd. The stock was sold at an average price of $549.06, for a total value of $118,047.90. Following the completion of the transaction, the senior vice president now directly owns 1,768 shares in the company, valued at $970,738.08. The trade was a 10.84% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 4,998 shares of company stock worth $2,611,577. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Trading Down 0.2%

ISRG opened at $512.18 on Friday. Intuitive Surgical, Inc. has a 1 year low of $413.82 and a 1 year high of $616.00. The stock has a fifty day moving average price of $526.57 and a 200 day moving average price of $538.46. The stock has a market cap of $183.57 billion, a price-to-earnings ratio of 79.90, a PEG ratio of 5.85 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping analysts’ consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The company had revenue of $2.25 billion during the quarter, compared to analysts’ expectations of $2.19 billion. During the same quarter in the previous year, the firm earned $1.50 earnings per share. As a group, sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of brokerages have weighed in on ISRG. Robert W. Baird lowered their price objective on Intuitive Surgical from $600.00 to $575.00 and set an “outperform” rating for the company in a research note on Wednesday, April 23rd. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Thursday, June 5th. BTIG Research set a $560.00 price target on Intuitive Surgical and gave the company a “buy” rating in a research report on Monday, April 14th. Truist Financial lowered their price target on Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating on the stock in a research report on Wednesday, April 23rd. Finally, Royal Bank of Canada lowered their price target on Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 23rd. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $588.95.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.